gms | German Medical Science

72. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Polnischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

06.06. - 09.06.2021

Can bilateral central drop foot be treated by bilaterally implanted peroneal nerve stimulators?

Können bilaterale zentrale Fußheberparesen durch beidseitig implantierte Peroneusstimulatoren behandelt werden?

Meeting Abstract

  • presenting/speaker Daniel Martin - Universitätsklinikum Carl Gustav Carus Dresden, Neurochirurgie, Dresden, Deutschland
  • Thomas Pinzer - Universitätsklinikum Carl Gustav Carus Dresden, Neurochirurgie, Dresden, Deutschland
  • Gabriele Schackert - Universitätsklinikum Carl Gustav Carus Dresden, Neurochirurgie, Dresden, Deutschland
  • Stephan B. Sobottka - Universitätsklinikum Carl Gustav Carus Dresden, Neurochirurgie, Dresden, Deutschland

Deutsche Gesellschaft für Neurochirurgie. 72. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Polnischen Gesellschaft für Neurochirurgie. sine loco [digital], 06.-09.06.2021. Düsseldorf: German Medical Science GMS Publishing House; 2021. DocV058

doi: 10.3205/21dgnc059, urn:nbn:de:0183-21dgnc0593

Published: June 4, 2021

© 2021 Martin et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Objective: Peroneal nerve stimulation using implantable devices was shown to be highly effective in patients with central drop foot caused by stroke or multiple sclerosis (MS). The devices lead to a significant better improvement of the dynamic gait pattern than foot orthosis or surface stimulation. Here, we describe for the first time the long-term outcome after bilateral implantations.

Methods: Between 2014 and 2016 two MS patients and one hereditary spastic paraplegia (HSP) patient were bilaterally treated with implantable peroneal nerve stimulators. Each stimulation system consisted of an external control unit, a heel switch, and an implantable 4-channel nerve stimulatorwith a 12-contact electrode cuff around the peroneal nerve. The heel switch, which is worn in a sock, triggers the initiation and termination of each stimulation sequence by a radiofrequency wireless signal to the external control unit. Extensive gait analysis including video documentation and evaluation of quality of life (QoL) was performed prior to surgery and after 6, 12, 48 months.

Results: All three patients showed an impressive improvement of their gait pattern including a mean improvement of 19% in the 20-m gait test, 29% in the 6-minute walking test, and 26% in the timed up-and-go test. QoL showed a marked improvement in all patients. One MS patient was wheelchair dependent and finally managed to walk with walking aids, the HSP patient impressively improved especially in gait endurance, and one MS patient developed a much better gait safety with an almost normal gait pattern.

Conclusion: We herewith show for the first time that bilateral drop foot can be successfully treated by bilateral peroneal nerve stimulators. The stimulator systems work independently and are separately triggered by the respective heel switch of the foot that is lifted from the ground. The bilateral implantation led to an impressive improvement of the gait pattern in all three patients with marked improvements in gait analysis and QoL assessment. With a follow-up of more than 4 years without technical and surgical complications bilateral implanted peroneal nerve stimulators seem to be a good treatment option for patients with bilateral drop foot.